Clinical Trial Detail

NCT ID NCT03067051
Title Clinical Study to Assess the Safety and Adequacy of Effectiveness of the SpectraCure P18 System
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors SpectraCure AB
Indications

prostate cancer

Therapies

Verteporfin

Age Groups: senior adult

No variant requirements are available.